Page 5 of 5
Scheme 7.
Journal of the American Chemical Society
Graduate Fellowship (DGE-1144085). Dr. Guan Wu is
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
thanked for assistance with X-ray crystallography.
References
1
Dalisay, D. S.; Morinaka, B. I.; Skepper, C. K.; Molinski, T.
F. J. Am. Chem. Soc. 2009, 131, 7552.
2
(
a) Searle, P. A.; Molinski, T. F. J. Am. Chem. Soc. 1995,
The enantioselective total synthesis of (+)-
muironolide A resulted in the adjustment of con-
figuration at C21 and reassignment of the absolute
configuration of the natural product. Delivering 25
mg of the natural product in the first unoptimized
effort, over 250 times the amount isolated from the
natural sources, it paves a way for a more systemat-
ic evaluation of the biological profile of muironolide
A. Perhaps more importantly, this work is a high-
light of the powerful combination of nanoscale
NMR analysis with total synthesis for uncovering
the full potential of “nearly extinct”, exceedingly
rare components of natural product extracts.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
117, 8126. (b) Searle, P. A.; Molinski, T. F.; Brzezinski, L. J.;
Leahy, J. W. J. Am. Chem. Soc. 1996, 118, 9422. (c) Molinski,
T. F. Tetrahedron Lett. 1996, 37, 7879.
3
Molinski, T. F. Nat. Prod. Rep. 2010, 27, 321.
The protecting groups were defined after preliminary exper-
4
imentation.
5
Xiao, Q.; Young, K.; Zakarian, A. Org. Lett. 2013, 15, 3314.
(a) Flores, B.; Molinski, T. F. Org. Lett. 2011, 13, 3932. (b)
6
Shaner, C. E.; Ferrence, G. M.; Mitchell, A. T. Synlett. 2013, 24,
1
861.
7
Fürstner, A.; Feyen, F.; Prinz, H.; Waldmann, H.; Angew.
Chem. Int. Ed. 2003, 42, 5361.
8
Kister, J.; Mioskowski, C. J. Org. Chem. 2007, 72, 3925.
Perryman, M. S.; Harris, M. E.; Foster, J. L.; Joshi, A.;
9
Clarkson, G. J.; Fox. D. J. Chem. Commun. 2013, 49, 10022.
1
0
See supporting information for its synthesis.
Corresponding Author
11
(
a) Tan, C-H.; Holmes, A. B. Chem. Eur. J. 2001, 7, 1845.
(
b) Araoz, R.; Servent, D.; Molgó, J.; Iorga, B. I.; Fruchart-
Present Addresses
Gaillard, C.; Benoit, E.; Gu, Z.; Stivala, C.; Zakarian, A. J. Am.
Chem. Soc. 2011, 133, 10499. (c) Lu, C.-D.; Zakarian, A. Org.
Lett. 2007, 9, 3161.
‡
Boehringer Ingelheim Shanghai Pharmaceuticals Co.,
Ltd., No. 1010 Longdong Avenue, Zhangjiang, Shang-
hai 201203, China
12
Beaulieu, L-P, B.; Zimmer, L. E.; Gagnon, A.; Charette, A.
B. Chem. Eur. J. 2012, 18, 14784.
13
Author Contributions
Young, K.; Xiao, Q.; Zakarian, A. Eur. J. Org. Chem. 2015,
2337.
†
authors contributed equally.
14
Liu, Y.; Wang, Q.; Zhang, Q.; Huang, J.; Nie, L.; Chen, J.;
Supporting Information
Cao, W.; Wu, X. J. Org. Chem. 2013, 78, 12009.
Detailed experimental procedures, copies of
NMR spectra, CD measurements. This material is
available free of charge via the Internet at
http://pubs.acs.org.
15
Parenty, A.; Moreau, X.; Niel, G.; Campagne, J. M. Chem.
Rev. 2013, 113, PR1-PR40.
16
The structure of 20 was confirmed by chemical correlation
to 14.
17
Palmer, C. F.; Parry, P. K.; Roberts, S. M.; Sik, V. J. Chem.
Soc., Perkin Trans. 1, 1992, 8, 1021.
ACKNOWLEDGMENT
We thank Professor Molinski for insightful discus-
sions and for performing the CD measurements of 3.
This work is supported by the NSF CHE-1463819,
Amgen, and Eli Lilly. K.Y. is supported by an NSF
ACS Paragon Plus Environment